Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
THE LEADING PHARMACEUTICAL COMPANY IN BOSNIA AND HERZEGOVINA
We are committed to meeting the expectations of our customers, shareholders and employees.
Investors
Bosnalijek d.d. is in the official quotation of the Sarajevo Stock Exchange (www.sase.ba) under ticker symbol BSNLR. We regularly rank among the top 5 most liquid stocks on the SASE and are classified in the SASX - 10 index. In this section of You can find more information on our business operations our web page.
BSNLR (BAM) KM
Average price: BAM
Change:
Best bid price: BAM
Best ask price: BAM
Volume:
Value: BAM
Number of transactions:
News
NOTICE/RECONVENING REGULAR ANNUAL ASSEMBLY
NOTICE ON RECONVENING THE REGULAR ANNUAL GENERAL ASSEMBLY OF BOSNALIJEK JSC
Based on the Decision No 2427/23 of 14 June 2023, the Supervisory Board of the Bosnalijek JSC, in accordance with provisions of Article 233 Paragraph 2 to 4 of the Company Law of Federation of BIH and Article 55 Paragraph 2 and 3 of the Statute of Bosnalijek JSC, the Supervisory Board publishes:
NOTICE ON CONVENING THE REGULAR ANNUAL GENERAL ASSEMBLY OF BOSNALIJEK JSC
Based on the Decision No 2131/23 of 22 May 2023, the Supervisory Board of the Bosnalijek JSC, in accordance with provisions of Article 230 Paragraph 1 of the current Law on Business Companies and Article 48 Paragraph 1 of the Statute of Bosnalijek JSC, publishes
Based on the Decision No 2427/23 of 14 June 2023, the Supervisory Board of the Bosnalijek JSC, in accordance with provisions of Article 233 Paragraph 2 to 4 of the Company Law of Federation of BIH and Article 55 Paragraph 2 and 3 of the Statute of Bosnalijek JSC, the Supervisory Board publishes: